SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
July 26, 2024 12:11 ET
|
Pomerantz LLP
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. (“Skye” or the “Company”) (NASDAQ: SKYE). Such investors are...
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
July 26, 2024 08:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter...
United States Intraocular Lens Market Set for Expansion by 2032, Reveals In-Depth Market Analysis
July 26, 2024 07:23 ET
|
Research and Markets
Dublin, July 26, 2024 (GLOBE NEWSWIRE) -- The "United States Intraocular Lens Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032" report has been added to ...
EssilorLuxottica: Q2/H1 2024 Results - Sound revenue growth, margins expanding, two acquisitions in line with strategy
July 25, 2024 12:00 ET
|
EssilorLuxottica
Q2/H1 2024 Results Sound revenue growth, margins expanding, two acquisitions in line with strategy Revenue growing by 5.2% in Q2 at constant exchange rates1, +5.3% in H1EMEA as the driving region,...
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy
July 25, 2024 06:30 ET
|
Ocugen
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
[Latest] US Fitness Tracker Market Size/Share Worth USD 35.8 Billion by 2033 at a 15.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 25, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Fitness Tracker Market Size, Trends and Insights By Type (Smart Watches,...
Nicox : Recrutement du dernier patient aux Etats- Unis dans l’étude clinique de phase 3 Denali sur NCX 470
July 25, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox : Recrutement du dernier patient aux Etats-Unis dans l’étude clinique de phase 3 Denali sur NCX 470 Le recrutement se poursuit en Chine, avec les premiers résultats...
Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470
July 25, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470 Recruitment continues in China, on track for topline results in H2 2025 NCX 470 demonstrated...
US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold Agglutinin Disease
July 24, 2024 14:00 ET
|
Spherix Global Insights
EXTON, PA, July 24, 2024 (GLOBE NEWSWIRE) -- Autoimmune hemolytic anemia (AIHA) encompasses a group of rare disorders characterized by the destruction of red blood cells due to autoantibodies. Among...
Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Spherix Global Insights
July 24, 2024 09:56 ET
|
Spherix Global Insights
EXTON, PA., June 20, 2024, July 24, 2024 (GLOBE NEWSWIRE) -- The American Society of Retinal Specialists (ASRS) annual meeting held last week in Stockholm, Sweden, showcased groundbreaking...